Rosen Oliver 4
4 · SQZ Biotechnologies Co · Filed Feb 25, 2021
Insider Transaction Report
Form 4
Rosen Oliver
Chief Medical Officer
Transactions
- Award
Stock Option
2021-02-23+75,625→ 75,625 totalExercise: $16.85Exp: 2031-02-22→ Common Stock (75,625 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable as to 25% of the underlying securities on February 23, 2022 and in 36 substantially equal monthly installments thereafter.